Combined gemcitabine with ferroptosis inducer erastin increased oxidative stress and lipid peroxidation of cancer cells and decreased the expression level of SLC7A11 protein (Fig. S3, Supplementary Materials). This evidence concerns the gene SLC7A11 and cancer.